CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	7 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2022
Cash Flows from Operating Activities
Net income (loss)	$ (13,469,409)	$ 6,642,013
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Income from marketable securities held in Trust Account	(2,453)	(1,924,056)
Transaction costs allocated to derivative warrant liabilities	1,382,307	0
Change in fair value of derivative warrant liabilities	10,987,689	(11,698,089)
Formation and operating costs funded through issuance of ordinary shares to the Sponsor	15,930	0
Changes in operating assets and liabilities:
Prepaid insurance	(1,203,245)	507,611
Accounts payable and accrued expenses	519,638	5,044,403
Net cash used in operating activities	(1,769,543)	(1,428,118)
Cash Flows from Investing Activities
Investment of cash into Trust Account	(319,412,500)	0
Net cash used in investing activities	(319,412,500)	0
Cash Flows from Financing Activities
Proceeds from note payable and advances from related party	300,000	1,428,118
Repayment of note payable and advances from related party	(300,000)	(55,752)
Proceeds from sale of Class A ordinary shares, net of transaction costs	309,233,680	0
Proceeds from sale of Private Placement Warrants	12,737,500	0
Net cash used in financing activities	321,971,180	1,372,366
Net decrease in cash	789,137	(55,752)
Cash - beginning of period	0	55,752
Cash - end of period	789,137	0
Supplemental disclosure of noncash investing and financing activities:
Deferred underwriting fees payable	$ 11,068,750	$ 11,068,750